David O’dOnnell

David O’dOnnell

Auto-generated profile, based on publicly available information

David O’dOnnell

The Edison Family Center for Genome Sciences and Systems Biology and the Center for Gut Microbiome and Nutrition Research, Washington University School of Medicine, St. Louis, MO, USA

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2019 in Science
Verified
Journal Article
Open access
PDF file
JGJeanette L. Gehrig
Jeanette L. Gehrig
SVSiddarth Venkatesh
Siddarth Venkatesh
HCHao-Wei Chang
Hao-Wei Chang
MHMatthew Hibberd
Matthew Hibberd
VKVanderlene L. Kung
Vanderlene L. Kung
JGJeffrey I. Gordon
Jeffrey I. Gordon
Malnutrition and dietary repair: Childhood malnutrition is accompanied by growth stunting and immaturity of the gut microbiota. Even after therapeutic intervention with standard commercial complementary foods, children may fail to thrive. Gehrig et al. and Raman et al. monitored metabolic parameters in healthy Bangladeshi children and those recovering from severe acute malnutrition. The authors investigated the interactions between therapeutic diet, microbiota development, and growth recovery. Diets were then designed using pig and mouse models to nudge the microbiota into a mature post-weaning state that might be expected to support the growth of a child. These were first tested in mice inoculated with age-characteristic gut microbiota. The designed diets entrained maturation of the children's microbiota and put their metabolic and growth profiles on a healthier trajectory. Science , this issue p. eaau4732 , p. eaau4735

13 January 2023 in Science
Verified
Journal Article
Closed access
DSDong-Oh Seo
Dong-Oh Seo
DODavid O’dOnnell
David O’dOnnell
NJNimansha Jain
Nimansha Jain
JUJason D. Ulrich
Jason D. Ulrich
JHJasmin Herz
Jasmin Herz
DHDavid Holtzman
David Holtzman
Tau-mediated neurodegeneration is a hallmark of Alzheimer’s disease. Primary tauopathies are characterized by pathological tau accumulation and neuronal and synaptic loss. Apolipoprotein E (ApoE)–mediated neuroinflammation is involved in the progression of tau-mediated neurodegeneration, and emerging evidence suggests that the gut microbiota regulates neuroinflammation in an APOE genotype–dependent manner. However, evidence of a causal link between the microbiota and tau-mediated neurodegeneration is lacking. In this study, we characterized a genetically engineered mouse model of tauopathy expressing human ApoE isoforms reared under germ-free conditions or after perturbation of their gut microbiota with antibiotics. Both of these manipulations reduced gliosis, tau pathology, and neurodegeneration in a sex- and ApoE isoform–dependent manner. The findings reveal mechanistic and translationally relevant interrelationships between the microbiota, neuroinflammation, and tau-mediated neurodegeneration.